International Journal of Internal Medicine

Objective To investigate the clinical effect of clopidogrel in the treatment of patients with acute angina pectoris in cardiovascular medicine; Methods 80 patients with acute angina pectoris admitted to the Department of Cardiovascular Medicine of our hospital from July 2020 to August 2022 were selected as the study subjects. They were divided into control group and observation group according to the order of admission. After admission, the patients in the control group were treated with conventional mode. The patients in the observation group were treated with clopidogrel on the basis of conventional treatment. The clinical effects of the two groups of patients after treatment intervention were compared and analyzed. At the same time, the clinical effects and safety of clopidogrel in the clinical treatment of patients with acute angina pectoris in cardiovascular medicine were analyzed in depth. Results After treatment, the overall effective rate of treatment in the control group was 80%, and that in the observation group was 97.5%. Compared with the two groups, the overall effective rate of treatment in the observation group was significantly better, with a significant difference (P<0.05). The incidence of adverse reactions after treatment in the control group was 35%, and that in the observation group was 5%. Compared with the two groups, the incidence of adverse reactions in the observation group was significantly lower, with a significant difference (P<0.05). Conclusion Clopidogrel has a significant therapeutic effect in the clinical treatment of acute angina pectoris in cardiovascular medicine, can effectively improve the level of cardiac function of patients, has a high safety, and can be vigorously promoted in clinical practice.

clopidogrel; Internal Medicine-Cardiovascular Department; Acute angina pectoris